Skip to content

BullFrog AI Holdings, Inc.

BFRG · XNAS

CIK 1829247fmd_19PAFDRCWBHM37PYMBWBB4EAZXManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2021 to Jun 30, 2026, 19 periods

Income Statement · Annual · Millions · USD
Line itemFY2021FY2022FY2023FY2024FY2025
Total revenues–00–0
Cost of revenue–00–0
Gross profit–00–0
Research and development01122
Total operating expenses12577
Operating income(1)(2)(5)(7)(7)
Interest expense00000
Other non-operating income (expense)(0)(0)000
Net income(1)(3)(5)(7)(6)
Net income to common shareholders––(5)(7)(6)
BullFrog AI Holdings, Inc. (BFRG) financial statements · FinancialMD